Insider Shareholders with Direct Ownership of Incyte Corp (INCY)
This section provides a comprehensive overview of the insiders with direct ownership of Incyte Corp (INCY). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
INCYTE CORP Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Herve Hoppenot
Director |
368,250 | 371,762 | 326,803 $34 Million | 22 |
Dec 08, 2025
Reduced 0.86%
|
| 440,282 | 0 | 281,190 $29.3 Million | 1 |
Jun 06, 2019
Added 43.91%
|
|
|
Pablo J Cagnoni
President, R&D |
226,670 | 4,657 | 234,800 $24.5 Million | 7 |
Jul 15, 2025
Added 6.95%
|
|
Christiana Stamoulis
EVP & Chief Financial Officer |
140,971 | 37,597 | 125,759 $13.1 Million | 25 |
Jul 15, 2025
Added 8.12%
|
|
Paula J Swain
EVP, Human Resources |
107,258 | 53,557 | 106,482 $11.1 Million | 27 |
Jul 15, 2025
Added 5.69%
|
|
Yao Wenqing
EVP, Head of Discovery Chem |
42,152 | 74,903 | 98,575 $10.3 Million | 9 |
Jul 06, 2021
Reduced 0.41%
|
|
Mohamed Khairie Issa
EVP, Head of US Oncology |
85,252 | 0 | 85,252 $8.88 Million | 3 |
Jul 15, 2025
Added 9.33%
|
|
Maria E Pasquale
EVP & General Counsel |
118,237 | 77,035 | 69,724 $7.26 Million | 27 |
Jul 14, 2023
Added 12.18%
|
|
Steven H Stein
EVP & Chief Medical Officer |
201,987 | 234,326 | 63,129 $6.57 Million | 36 |
Dec 02, 2025
Reduced 24.15%
|
|
Patrick A Mayes
EVP & Chief Scientific Officer |
0 | 7,377 | 60,011 $6.25 Million | 3 |
Dec 11, 2025
Reduced 0.42%
|
|
Dashyant Dhanak
EVP & Chief Scientific Officer |
55,228 | 24,270 | 58,968 $6.14 Million | 31 |
Jul 14, 2023
Added 12.02%
|
|
Vijay K Iyengar
EVP, GMAPPS |
111,695 | 98,886 | 40,540 $4.22 Million | 33 |
Jul 16, 2025
Reduced 2.37%
|
|
Jonathan Elliott Dickinson
EVP, General Manager, Europe |
30,608 | 17,457 | 36,390 $3.79 Million | 21 |
Sep 12, 2024
Reduced 16.77%
|
|
William Meury
Chief Executive Officer |
36,101 | 0 | 36,101 $3.76 Million | 1 |
Jul 02, 2025
Added 50.0%
|
|
Barry P Flannelly
EVP & General Manager US |
169,177 | 175,490 | 35,149 $3.66 Million | 37 |
Jul 16, 2025
Reduced 3.67%
|
|
Paul Trower
Principal Accounting Officer |
16,767 | 9,190 | 32,268 $3.36 Million | 6 |
Jan 03, 2022
Reduced 4.15%
|
|
Lee Heeson
EVP, Head of Incyte Intl |
32,778 | 3,537 | 29,241 $3.05 Million | 4 |
Nov 03, 2025
Reduced 9.51%
|
|
Michael James Morrissey
EVP, Head of Tech. Operations |
60,576 | 81,626 | 27,507 $2.86 Million | 27 |
Dec 17, 2025
Reduced 13.58%
|
|
Sheila A. Denton
EVP & General Counsel |
60,063 | 34,150 | 26,569 $2.77 Million | 31 |
Nov 17, 2025
Reduced 1.04%
|
|
Paul J Clancy
Director |
18,980 | 0 | 23,235 $2.42 Million | 26 |
Sep 30, 2025
Added 1.21%
|
|
Thomas Tray
Principal Accounting Officer |
25,326 | 19,794 | 22,973 $2.39 Million | 29 |
Dec 19, 2025
Reduced 10.77%
|
|
Jean Jacques Bienaime
Director |
12,449 | 798 | 20,841 $2.17 Million | 8 |
Jun 10, 2025
Added 10.78%
|
|
Edmund Harrigan
Director |
18,510 | 0 | 20,608 $2.15 Million | 27 |
Sep 30, 2025
Added 1.38%
|
|
Jacqualyn A Fouse
Director |
14,523 | 0 | 19,326 $2.01 Million | 15 |
Jun 10, 2025
Added 11.53%
|
|
Wendy L Dixon
Director |
23,525 | 20,000 | 17,768 $1.85 Million | 10 |
Mar 31, 2022
Added 1.38%
|
|
Matteo Trotta
EVP, GM, Dermatology US |
15,735 | 719 | 15,016 $1.56 Million | 5 |
Jul 15, 2025
Added 25.95%
|
|
Katherine A High
Director |
11,920 | 0 | 13,341 $1.39 Million | 5 |
Jun 10, 2025
Added 15.88%
|
|
Otis W Brawley
Director |
11,252 | 0 | 11,252 $1.17 Million | 5 |
Jun 10, 2025
Added 18.29%
|
|
Richard A. Hoffman
EVP & General Counsel |
9,466 | 0 | 9,466 $985,883 | 1 |
Dec 01, 2025
Added 50.0%
|
|
David H Gardner
EVP, Chief Strategy Officer |
9,429 | 0 | 9,429 $982,030 | 1 |
Sep 22, 2025
Added 50.0%
|
|
Susanne Schaffert
Director |
9,478 | 2,089 | 7,389 $769,564 | 7 |
Jun 10, 2025
Added 25.42%
|
|
Ramitpal K Basi
EVP, Human Resources |
6,506 | 0 | 6,506 $677,599 | 1 |
Aug 25, 2025
Added 50.0%
|